The High Flux Isotope Reactor at Oak Ridge National Laboratory
New Batch of Strontium-89 Available Soon
A new batch of strontium-89 (Sr-89) will be available through the U.S. Department of Energy Isotope Program (DOE IP) in December 2019. The radioactive isotope is most commonly used in cancer therapy to relieve pain associated with cancer that has spread to bone.
Strontium-89 has a half-life of 50.563 days and is produced via neutron capture by an enriched strontium-88 oxide target using the DOE's High Flux Isotope Reactor, located at Oak Ridge National Laboratory. The product has a radionuclidic purity of >99.8% and is sold as strontium chloride solution in 0.1 N HCI.
For further inquiries about Sr-89, contact the NIDC at firstname.lastname@example.org or click below to request a quote.